Search results
Do Virtual Behavior Interventions Lower T1D Distress?
Medscape· 11 hours agoEducational and emotion-focused approaches conducted online in groups reduced diabetes distress and...
Q&A: Liquid low-calorie or low-carb keto diet can reverse type 2 diabetes, research shows
Medical Xpress· 23 hours agoSaslow reviewed a large body of clinical trial evidence for type 2 diabetes remission and reversal through various diets and found that both a liquid low-calorie eating plan ...
Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
Pharmaceutical Technology via Yahoo Finance· 4 days agoTheir success has meant other players in the industry have been making a push into diabetes – and...
Using Ozempic Could Reduce Your Risk of Developing Osteoarthritis
Verywell Health via Yahoo News· 33 minutes agoNew research suggests people with obesity who take semaglutide, have a lower rate of developing...
Gateway - Quartz
Quartz· 6 hours agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks ...
Gilead's New Revelation For Its Weight-Loss Contender
Investor's Business Daily· 22 hours agoOn Friday, shares of Gilead Sciences (GILD) shot up 2.4% after a poster published ahead of the...
Gateway - Quartz
Quartz· 9 hours ago“Lilly’s first quarter performance reflects solid year-over-year revenue growth with strong sales of Mounjaro... CEO David A. Ricks in a press release. The company’s revenue grew 26% year over ...
Gateway - Quartz
Quartz· 10 hours agoInflation Reduction Act of 2022 passed by the US senate on Aug. 7 was supposed to include, among other measures to lower drug costs, a cap on insulin copays for all insured ...
Gateway - Quartz
Quartz· 15 hours agoNordisk trademarks, to stop them from advertising and selling counterfeits of its semaglutide products. The world’s largest company for diabetes treatments alleges illegal ...
Gateway - Quartz
Quartz· 18 hours agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma ...
